Deciphera Pharmaceuticals... (DCPH)
NASDAQ: DCPH
· Real-Time Price · USD
25.59
0.02 (0.08%)
At close: Jun 10, 2024, 10:00 PM
Deciphera Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -45.08M | -47.19M | -49.58M | -48.56M | -49.61M | -45.94M | -43.04M | -43.06M | -46.89M | -88.39M | -79.84M | -70.43M | -61.3M |
Depreciation & Amortization | 1.6M | 456K | 465K | 571K | 608K | 601K | 742K | 820K | 783K | 780K | 759K | 743K | 732K |
Stock-Based Compensation | 10.17M | 14.07M | 11.16M | 12.86M | 12.51M | 12.31M | 12.37M | 12.99M | 14.27M | 10.79M | 11.79M | 12.37M | 11.12M |
Other Working Capital | -10.88M | 2.83M | 6.74M | 3.17M | 188K | -5.76M | 6.47M | -11.41M | -17.38M | 36.21M | 13.96M | 9.6M | -26.1M |
Other Non-Cash Items | 20.45M | 1.14M | 1.12M | 1.11M | -464K | 184K | 469K | 1M | 954K | 1.31M | 5.4M | 1.32M | 1.2M |
Deferred Income Tax | n/a | -1.85M | -2.03M | -1.95M | n/a | n/a | n/a | -33K | 255K | 390K | 545K | 482K | 365K |
Change in Working Capital | -19.62M | 4.57M | 9.05M | -2.65M | -12.5M | -2.32M | 8.63M | -17.24M | -20.72M | 8.34M | 7.89M | 4.03M | -19.43M |
Operating Cash Flow | -54.59M | -28.81M | -29.81M | -38.63M | -49.45M | -35.16M | -20.83M | -45.52M | -51.35M | -67.18M | -54M | -51.97M | -67.68M |
Capital Expenditures | -146K | -63K | -62K | -293K | -360K | -268K | -573K | -287K | n/a | 1.11M | -6.01M | -432K | -637K |
Cash Acquisitions | n/a | -2.26M | -41.47M | -4.65M | 35.05M | n/a | 5.5M | 103.91M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -20.26M | -59.66M | -33.78M | -106.28M | -122.86M | -82.17M | -58.71M | -181.88M | n/a | -21.66M | -101.6M | -180.3M | -31.82M |
Sales Maturities Of Investments | 83.04M | 61.92M | 75.25M | 110.93M | 87.81M | 98.46M | 53.21M | 77.98M | 59.65M | 119.51M | 122.05M | 120.28M | 156.37M |
Other Investing Acitivies | 62.78M | 2.26M | 41.47M | 4.65M | -35.05M | 287K | -5.5M | -103.91M | n/a | -7K | -4M | n/a | n/a |
Investing Cash Flow | 62.63M | 2.2M | 41.4M | 4.36M | -35.41M | 16.3M | -6.07M | -104.19M | 59.65M | 98.95M | 14.44M | -60.45M | 123.91M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 522K | 890K | 15.59M | 838K | 134.69M | 478K | 209K | 164.22M | 83K | 1.98M | 1.71M | 1.68M | 9.52M |
Financial Cash Flow | 522K | 890K | 15.59M | 838K | 134.69M | 478K | 209K | 164.22M | 83K | 1.98M | 1.71M | 1.68M | 9.52M |
Net Cash Flow | 7.72M | -24.58M | 26.69M | -33.24M | 49.9M | -17.8M | -27.16M | 14.37M | 8.27M | 33.87M | -37.76M | -110.7M | 65.75M |
Free Cash Flow | -54.73M | -28.87M | -29.87M | -38.92M | -49.81M | -35.43M | -21.4M | -45.81M | -51.35M | -66.07M | -60.01M | -52.4M | -68.32M |